KPF
ARRY

K2 Principal Fund’s Array Biopharma Inc ARRY Stock Holding History

K2 Principal Fund’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-54,539
Closed -$2.53M – 397
2019
Q2 		$2.53M Buy
+54,539
New +$1.53M 0.31% 111

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

K2 Principal Fund's ARRY Position: Q3 2019 in Review

K2 Principal Fund sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 54,539 shares — an estimated $2.53M sold.

K2 Principal Fund first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $2.53M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • K2 Principal Fund reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • K2 Principal Fund sold 54,539 Array Biopharma Inc shares in Q3 2019, an estimated $2.53M.
  • K2 Principal Fund first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • K2 Principal Fund's Array Biopharma Inc position peaked at $2.53M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on K2 Principal Fund's 13F filing for Q3 2019, filed 15 Nov 2019.